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The fields of structural biology and soft matter have independently sought out fundamental prin-
ciples to rationalize protein crystallization. Yet the conceptual differences and the limited overlap
between the two disciplines have thus far prevented a comprehensive understanding of the phe-
nomenon to emerge. We conduct a computational study of proteins from the rubredoxin family
that bridges the two fields. Using atomistic simulations, we characterize their crystal contacts, and
accordingly parameterize patchy particle models. Comparing the phase diagrams of these schematic
models with experimental results enables us to critically examine the assumptions behind the two
approaches. The study also reveals features of protein-protein interactions that can be leveraged to
crystallize proteins more generally.
I. INTRODUCTION
In spite of the recent advances in NMR techniques [1],
X-ray and neutron diffraction crystallography remain the
methods of choice for high-precision protein structure de-
termination. Sophisticated screening methods and the
parallel testing of several different crystallization condi-
tions have significantly increased the number of deposited
protein structures and complexes [2]. Yet the lack of sys-
tematic ways to crystallize proteins still limits the timely
and cost-effective use of crystallography. This experi-
mental bottleneck notably constrains our understanding
of certain biochemical mechanisms and our ability to de-
sign better drugs and biomaterials [2–11]. Developing a
more quantitative characterization of protein crystalliza-
tion is therefore fundamental to advance both biological
and bio-inspired research.
From a physical viewpoint, protein crystallization
should follow from a detailed description of protein-
protein interactions [2, 12–14]. In contrast to the interac-
tions that drive protein complex formation and protein-
target association, which are on average stronger and
evolutionarily tuned to be selective, the interactions that
drive crystallization are thought to be non-specific[15].
Two recent studies, however, present crystal contacts un-
der a more probing light. First, Cies´lik and Derewenda
found that crystal contacts are enriched for glycine and
small hydrophobic residues, and depleted in large po-
lar residues with high side-chain entropy, such as ly-
sine and glutamic acids [16]. Second, mining a database
recording the output of hundreds of crystallization ex-
periments, Price et al. found that proteins with a
large fraction of glycine and alanine on their surface are
more likely to have been successfully crystallized [17].
These observations provide immediate statistical sup-
port for the surface entropy reduction (SER) mutage-
nesis strategy, which recommends replacing high-entropy
surface residues with alanine to facilitate crystal forma-
tion [12, 18, 19]. More fundamentally, these studies also
suggest that crystal contacts correspond to non-randomly
selected regions of the protein surface. To some degree,
it should thus be possible to control these weak yet direc-
tional, i.e. patchy, protein-protein interactions by tuning
the solution conditions or by mutating certain surface
residues. A key missing insight to developing crystalliza-
tion strategies is thus understanding the context in which
these interactions can result in regular protein assembly.
The soft matter viewpoint on particle interactions
presents a possible answer to this challenge. The ob-
servation that short-range isotropic attraction between
particles results in a gas-liquid critical point that lies be-
low the crystal solubility regime [20, 21], in particular,
offers a first analogy for the solution behavior of pro-
teins [22–24]. In these model systems successful crystal-
lization can most easily be achieved in the region between
the solubility line, above which the system does not ag-
gregate because the disperse phase is stable, and the crit-
ical point, below which the system typically forms “amor-
phous” materials that are useless for crystallography [25].
Though appealing in their simplicity, isotropic descrip-
tion of protein-protein interactions between proteins are,
however, too simplistic [22, 26–29]. Partly in response
to this difficulty, a broad array of schematic models with
anisotropic, directional attraction, i.e., patchy models,
have been developed [30, 31].
Although both the structural biology and the soft mat-
ter fields target the same problem, a large gap between
the two research lines remains to be filled before synergis-
tic experimental guidance can be provided. In particular,
although anisotropy plays a key role in physical models
for protein crystallization [32–34], little characterization
of the directional interaction between proteins at crystal
contacts has been done [35], leaving most of the phys-
ical assumptions behind patchy models untested. Can
these models explain the results of crystallographic ex-
periments if they are parameterized using actual protein-
protein interactions? If yes, the relation between the re-
ar
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2sulting phase diagrams and protein-protein interactions
should allow one to rationally alter these interactions, in
order to control protein crystal assembly.
In this article, we answer this question for simple pro-
teins of the rubredoxin family, using a hybrid atomistic
and schematic simulation approach. Classical atomistic
simulations characterize the differences and similarities
in the crystal contact interactions of three closely re-
lated small globular proteins from the rubredoxin fam-
ily: (a) the wild-type from Pyrococcus furious (wt-RbPf,
PDB code: 1BRF) [36], (b) its W3Y/I23V/L32I mutant
(mut-RbPf, PDB code: 1IU5) [37], and (c) the W4L/R5S
mutant from Pyrococcus abyssi (mut-RbPa, PDB code:
1YK4) [38]. Through a comparative analysis, we identify
the molecular basis of these protein-protein interactions,
and parameterize patchy models whose phase diagrams
are then compared with experimental crystallization con-
ditions. The validity of this strategy is supported by the
recent success of multiscale descriptions of protein aggre-
gation [39]. By showing that the models and the exper-
imental results agree fairly well, we find that increasing
the solution temperature may sometimes produce better
crystallization conditions. We also suggest ways to im-
prove SER and sketch a framework for developing phys-
ically representative patchy models of proteins.
The plan of this paper is as follows. In Section II, we
describe the atomistic and schematic models as well as
the corresponding molecular dynamics (MD) and Monte
Carlo methodologies. In Section III, we report the MD
potential of mean force (PMF) analysis for each protein
and the phase diagrams of the corresponding schematic
models. We then compare these phase diagrams to exper-
imental crystallization conditions, which help understand
the role of salt in rubredoxin crystallization. Section IV
discusses how our findings illuminate the SER method
and the patchy particle models of proteins. Section V
summarizes our conclusions and discusses possible future
research directions.
II. MODELS AND SIMULATION METHODS
Hypethermophilic rubredoxins are an excellent model
system for the computational study we present here.
First, their core is characterized by more hydrogen bond-
ing and electrostatic interactions than those of their
mesophilic counterparts, which reduces their conforma-
tional flexibility and justifies the use of relatively short
molecular dynamics simulations to capture the relevant
protein dynamics. Second, these proteins have a tight hy-
drophobic core packing, which motivates the hard sphere
analogy. Third, they are structurally stable over a wide
temperature range, which makes the PMF (and thus
the phase diagram) predictions reasonably transferable
to temperatures beyond those used in the molecular dy-
namics simulations [40].
A. Iron site model and Molecular Dynamics
simulations.
Molecular dynamics (MD) simulations are performed
with the Gromacs package [41] using the Amber99sb
forcefield [42] and explicit TIP4P water with Ewald sum-
mation [43]. The full list of simulation parameters is re-
ported in Table I.
TABLE I. MD simulations parameters
Parameter Value
Forcefield Amber99sb [42]
Water model Tip4pEW [43]
Ions Aqvist [44]
Temperature 300 K
Temperature control Nose´-Hoover thermostat [45, 46]
Pressure 1 bar
Pressure control Parrinello-Rahman barostat [47]
Box dimension 6 nm×6 nm×12 nm
Periodic boundary conditions xyz
Electrostatic method PME [48]
Coulomb radius 1.4 nm
Van der Waals method Cut-off
Van der Waals radius 1.4 nm
Integration step 2 fs
Constraint algorithm Lincs [49]
Energy minimization steepest-descent
Salt concentration 45 mM/3 M of NaCl
Spring constant 5000 kJ/(mol nm2)
FIG. 1. Model system used to obtain the force constant pa-
rameters of the Fe-S bonds.
Because of the unavailability of parameters for the iron
site, we build a bonded model whose initial structure is
the crystal structure of mut-RbPa with the four Cα atoms
of the cysteines replaced by hydrogens (Fig. 1). To de-
termine the equilibrium bond length of Fe-S, this model
system is optimized using Gaussian 03 [50] with B3LYP
exchange-correlation functional [51, 52] and 6-31+g(d)/
6-31++g(d,p)/ 6-311++g(d,p)/ 6-311++g(2d,2p) basis
sets. The predicted distances conform to the crystal
structure. The harmonic bond stretching force constant
is calculated using the scheme presented in Ref. 53. The
frequency analysis is performed using Gaussian 03 with
3the same functional and basis set used to generate the
Hessian of the optimized structure in Cartesian coordi-
nates. For each Fe-S bond, a 3× 3 matrix
∂2E
∂xFe∂xS
∂2E
∂xFe∂yS
∂2E
∂xFe∂zS
∂2E
∂yFe∂xS
∂2E
∂yFe∂yS
∂2E
∂yFe∂zS
∂2E
∂zFe∂xS
∂2E
∂zFe∂yS
∂2E
∂zFe∂zS

is extracted from the Hessian. Its eigenvalues λi and
eigenvectors vi are obtained through diagonalization.
The harmonic bond stretching force constant is then cal-
culated as
kFe−S =
1
2
3∑
i=1
λi|u · vi|, (1)
where u is the normalized vector linking the iron center
to the sulfur. The coefficient 12 conforms to the functional
form of the Amber force field. The parameters for the ox-
idized and the reduced form of the site using the different
basis sets are reported in Table II. The small changes in
the resulting parameters across the different basis sets
indicate the robustness of the model. For the purpose of
this study, we use the Fe(III)-S 6-311++g(2d,2p) model
parameterization.
TABLE II. Parameters for the iron site determined using ab
initio calculations
Bond type Basis set
Bond Force constant
length (A˚) (kcal mol−1A˚−2)
Fe(III)-S
6-31+g(d) 2.317 81.33
6-31++g(d,p) 2.317 81.35
6-311++g(d,p) 2.325 79.56
6-311++g(2d,2p) 2.322 79.68
Fe(II)-S
6-31+g(d) 2.416 44.02
6-31++g(d,p) 2.415 43.82
6-311++g(d,p) 2.425 43.57
6-311++g(2d,2p) 2.419 42.90
We verify the agreement between the PDB structure
and the electron density map with MolProbity [54]. For
wt-RbPf, a clash was detected and the rotamer of Glu49
was accordingly adjusted. This PDB structure is then
immersed in water and ions, which neutralize the protein
charge and recreate the high-salt experimental crystal-
lization conditions. Steepest descent energy minimiza-
tion and 100 ps-long simulations at constant volume V
and temperature T=300 K (constant NVT ensemble)
with position restraints on the heavy atoms follow, in
order to equilibrate the system temperature and relax
the solvent.
Because the proteins in these study have been previ-
ously crystallized, the crystal contacts, i.e. the regions on
the protein surface that are within 4 A˚ from each other in
the observed protein crystal, are unique and easily iden-
tified from the PDB structure. We follow the soft matter
hypothesis that these regions trigger crystal formation, so
they correspond to the attractive patches in the coarse-
grained model described in the following section. This
hypothesis is validated by the rest of our analysis.
The PMF of each protein’s every crystal contact is de-
termined using the umbrella sampling and weighted his-
togram package implemented in Gromacs [55]. The prin-
cipal axes of the inertia tensor of the interface provide two
axes in the plane of the interface, and the third, which
is orthogonal to the interface, is used as reaction coor-
dinate. Starting configurations are generated by pulling
the center of mass of one protein along the reaction co-
ordinate while keeping the other protein fixed. During
the pulling, we control the reciprocal orientation of the
two proteins as in Ref. 35. We first determine the four
most stable heavy atoms in the structure from individ-
ual MD simulations, such that the tetrahedron defined
by these four centers spans most of the protein struc-
ture. We use the Cα of Ile7, Pro19, Asp35 and Glu52 for
wt-RbPf and mut-RbPa. For mut-RbPf, we use the Cα
of Lys50 instead of Glu52, because the coordinates of the
latter residue are not reported in the PDB file. We then
restrain the angles between the edges of the two tetrahe-
dra with a spring constant of 5000 kJ/(mol rad2). These
restraints prevent the proteins from rotating with respect
to each other, yet allow ample freedom for both the flex-
ible elements of the protein backbone and the sidechains
to fluctuate, as shown by the typical fluctuation range of
the Cαs in the loops and C-terminus of the protein [56]
(Fig. 2). The starting configurations are sampled every
1 A˚ up to a distance of 10 A˚ with a spring constant of
5000 kJ/(mol nm2). A production run of 40 ns follows a
10 ns equilibration at constant temperature (300 K) and
pressure (1 bar).
FIG. 2. Root mean-sqaured displacement (rmsd) fluctuations
of the Cαs along the umbrella sampling simulations. The
regions of higher flexibility correspond to the protein’s loops
(around residues 7, 20, 35 and 42) and C-terminus, which are
in qualitative agreement with earlier NMR studies [57].
We estimate the umbrella sampling accuracy from 100
4bootstraps [55]. The standard deviation associated with
the PMF minimum is 2–3 kJ/mol, which corresponds to
a 10-20% relative error on the interaction strength. Using
three replicates of the simulations provides a similar esti-
mate. The uncertainty is comparable with the systematic
errors introduced by a given choice of forcefield [58], and
is thus in line with the overall robustness of the schematic
model parameters.
The angular component of the interaction is obtained
from four independent 5 ns-long simulations that restrain
the distance between the centers of mass of the two pro-
teins for each interface using a spring constant of 1000
kJ/(mol nm2). To examine the role of salt in Sec. III D,
we perform 4 ns-long MD simulations during which the
proteins’ center of mass and reciprocal orientations are
constrained to their crystal form. The ion distribution
around the interface is measured every 20 ps. Their num-
ber density is obtained by normalizing over the available
volume defined as the total volume minus the volume
occupied by two spheres of diameter σ centered at the
proteins center of mass.
B. Patchy particle model.
In order to estimate the phase diagram of each pro-
tein and to identify their facile crystallization regime, we
model proteins as hard spheres decorated by attractive
patches representing the crystal contacts (Fig. 3). Each
particle carries i = 1, . . . , n pairs of patches. Patch 2i in-
teracts only with 2i− 1, as in the Sear model [59], while
the range and width of the interactions are independent
parameters, as in the Kern-Frenkel model [32]. In con-
trast to the Sear and the Kern-Frenkel models, which
both assume the same interaction form for each pair of
patches, we allow the interaction to vary from one pair
of patches to another, capturing the chemically hetero-
geneous nature of the crystal contact interactions [60].
The interaction between particles 1 and 2, whose cen-
ters are a distance r12 apart, is thus
φ(r12,Ω1,Ω2) =φHS(r12) +
∑n
i=1[φ2i,2i−1(r12,Ω1,Ω2)
+ φ2i−1,2i(r12,Ω1,Ω2)], (2)
where Ω1 and Ω2 are the Euler angles. A hard-sphere
(HS) potential captures the volume exclusion
φHS =
{
∞ r ≤ σ
0 r > σ,
(3)
where σ is the diameter of the particle. The patch-patch
interaction is the product of a radial and an angular com-
ponent
φ2i,2i−1(r12,Ω1,Ω2) = ψ2i,2i−1(r12)ω2i,2i−1(Ω1,Ω2),
(4)
where
ψ2i,2i−1 =
{
−i r ≤ λi
0 r > λi
(5)
FIG. 3. Coarse-grained representation of the protein crystal
(A) through a patchy particle model (B). The blue spheres
are proteins on which each pair of patches corresponds to
the crystal interface of the same color. C: schematic of the
interaction between two particles through patch 2i and patch
2i−1. The colored region represents the angular width of the
patch.
TABLE III. Model parameters for wt-RbPf, wt-RbPf at 45
mM of NaCl (low salt), mut-RbPf and mut-RbPa
- wt-RbPf
wt-RbPf
mut-RbPf mut-RbPa
(low salt)
σ(nm) 2.2 2.2 2.2 1.9
λ1 (σ) 1.09 1.1 1.09 1.15
1 (kBT ) 3.7 0.6 3.7 8.4
cos δ1 0.9 0.89 0.9 0.93
cos δ2 0.89 0.89 0.89 0.89
λ2 (σ) 1.1 1.1 1.1 1.1
2 (kBT ) 2.8 2.4 4.7 7.6
cos δ3 0.95 0.95 0.95 0.95
cos δ4 0.92 0.92 0.95 0.92
λ3 (σ) 1.15 1.15 1.15 -
3 (kBT ) 3.3 2.9 3.3 -
cos δ5 0.89 0.89 0.89 -
cos δ6 0.89 0.89 0.89 -
and
ω2i,2i−1(Ω1,Ω2) =
{
1 θ1,2i ≤ δ2i and θ2,2i−1 ≤ δ2i−1
0 otherwise
.
(6)
The interaction range between patch 2i and patch 2i−1 is
λi, δ2i is the semi-width of patch 2i, and θ1,2i is the angle
between the vector r12 and the vector defining patch 2i
on particle 1, as illustrated in Fig. 3C. An analogous def-
inition holds for θ2,2i−1. Following the soft matter con-
vention, the model parameters are expressed in reduced
units [61]. Lengths are in units of the sphere diame-
ter σ, energies are in units of 300KkB (∼ 2.49 kJ/mol),
5where kB is Boltzmann’s constant, and temperatures are
in units of 300K.
The model parameters are fully determined from the
MD simulations described above (Table III). The parti-
cle diameter σ is set by the range of the strong repul-
sion between proteins, the depth of the well i corre-
sponds to the PMF minimum, and the effective interac-
tion range λi is such that the specific patch contribution
to the second virial coefficient matches that of the ac-
tual radial profile of the protein-protein interaction at
the crystal contact. The angular distribution of the con-
figurational space sets the width of the patches defined
as δ2i = min[asin(
1
2λi
), acos(1 − 2σ˜2i)], where σ˜2i is the
standard deviation of cos(δ2i) distribution from the MD
simulations. The constraint sin(δ2i) < (2λi)
−1 guaran-
tees that no patch can form more than one bond. The
location of the patches on the sphere is obtained from the
crystal contacts on the protein (Fig. 3A and B). The pro-
tein crystal recorded in the PDB file is expanded using
PyMol. The centers of mass of each protein in the unit
cell are identified. The vectors connecting one protein’s
center of mass to its neighbors are then computed (the
cartesian coordinates of the patches are reported in Ta-
ble IV). Because of the P212121 symmetry of the protein
crystals in this study, each protein has six neighbors. In
the case of mut-RbPa, only four neighbors are sufficiently
close (surface distance less than 4 A˚) to be considered to
be interacting, which is why only four patches are re-
ported.
The gas-liquid line of the phase diagram is obtained
using the Gibbs ensemble method [62] and the critical
temperature and density using the law of rectilinear di-
ameters [61]. The solubility line is computed by inte-
grating the Clausius-Clapeyron equation starting from a
first coexistence point, determined using free energy cal-
culations and thermodynamic integration [61, 63] (the
methodological details are the same as in Ref. 64).
III. RESULTS
We describe below the MD results for the three pro-
teins’ crystal contacts and compare the experimental
crystallization conditions with the protein phase dia-
grams obtained by parameterizing the patchy particle
model with the MD results. We then analyze how salt
affects the protein interactions and phase diagrams, in or-
der to understand the high salt conditions used for crys-
tallizing rubredoxin.
A. Crystal contacts of wt-RbPf and mut-RbPf.
Figure 4 reports the solvated protein-protein interac-
tion as a function of the center of mass-center of mass
(COM-COM) distance and of the proteins’ relative ori-
entation for each crystal contact (1, 2, and 3) obtained
using MD simulations. The orientationally-constrained
potential of mean force (PMF) of wt-RbPf is first ob-
tained in 3 M NaCl aqueous solution (Fig. 4A). The PMF
minimum for interface 1a and 2a matches the observed
crystal distance, while the crystal distance of interface
3a, although not exactly at the minimum of the PMF, is
still within the attractive well. The interfaces are differ-
ently attractive and show a varying range of interactions.
The strong interface 1a contains a combination of neg-
atively and positively charged residues suggesting that
specific complementary amino acids come in contact and
trigger the interaction. We will explore this interface in
more details in Sec. III D. The relative abundance of ap-
olar residues [66, 67] in interfaces 2a and 3a compared
to interface 1a suggests that hydrophobicity here drives
the attraction. The major difference between these two
interfaces is the presence of a barrier for interface 2a,
which is likely caused by the interference of the disor-
dered C-terminus of one chain with the crystal packing.
The high B-factor of this region reported in the PDB file
suggests it is highly flexible. The C-terminus appears to
interact with the neighboring chain by forming a series of
backbone-backbone hydrogen bonds at crystal distance
(first minimum). When the two chains are at 2.5 nm
apart the connection breaks. The C-terminus becomes
very mobile and appears to impede the protein interac-
tion, which is the source of the free-energy barrier. This
oscillatory behavior in the PMF is thus likely unphysi-
cal and due to a combination of a poor choice of reaction
coordinate and the slow dynamics of the C-terminus. Al-
though in most cases constraining the movement along a
single direction that is orthogonal to the interface plane
is a reasonable approach for separating a pair of proteins,
here this setup effectively limits the energetically favor-
able configurations between the C-terminus and the other
chain by reducing the directions of approach between the
two chains. In addition, the attachment-detachment dy-
namics of the tail at intermediate distance is much slower
than the simulation time, which causes a poor equilibra-
tion of these simulations. As a result, the PMF profile of
this interface is less reliable than the others, although it
remains sufficiently accurate to parameterize the patchy
model.
The effect of the C-terminus tail is also evident in mut-
RbPf PMF (Fig. 4B). The mutations of this protein are
not involved in any crystal contact, which leaves the crys-
tal packing unchanged. The PDB file (PDB code: 1IU5),
however, does not specify coordinates for the C-terminus
tail, because the electron densities of these two residues
is too poor for accurate modeling [37]. We therefore com-
pute the PMF for interface 2b (identical to 2a) omitting
the C-terminus (deletion of Glu52 and Aps53). The re-
sulting profile does not show any significant barrier and
reaches a more negative free energy. This finding sup-
ports the negative effect of the disordered C-terminus
on crystal packing in agreement with the general under-
standing that highly-flexible regions of the protein may
hinder crystallization.
The N-terminal methionine and formylmethionine
6TABLE IV. Summary of the patches position and the crystal properties for the proteins in this study. The first section reports
the cartesian coordinates of the normalized vectors of the models patches. Patch 1 interacts with 2, patch 3 with 4 and patch
5 with 6. The second section describes the crystal unit cell: unit cell dimensions and positions of the proteins center of mass
within the unit cell. Both crystals have 4 proteins in their unit cell obtained by applying a two-fold screw axis symmetry along
each direction to the reference protein in the asymmetric unit cell. The unit cell properties are obtained from the PDB file
wt-RbPf and mut-RbPf mut-RbPa
patch x y z x y z
1 -0.7191 0.5659 -0.4032 0.6268 -0.2698 -0.731
2 0.7191 0.5659 -0.4032 -0.6268 -0.2698 -0.731
3 -0.3813 -0.1669 -0.9093 -0.008 -0.9288 0.3706
4 -0.3813 -0.1669 0.9093 -0.008 0.9288 0.3706
5 0.3475 -0.7668 0.5397
6 0.3475 0.7668 0.5397
unit cell (σ) 1.551 1.585 1.986 1.257 1.975 2.254
position within the unit cell (σ)
reference 0 0 0 0 0 0
screw axis along x 0.775 0.610 1.551 0.629 1.705 1.521
screw axis along y 0.359 0.793 0.558 1.249 0.988 0.394
screw axis along z 1.135 1.403 0.993 0.620 0.727 1.127
FIG. 4. PMF for wt-RbPf (A), mut-RbPf (B) and mut-RbPa (C). The filled circles indicate the COM-COM distance in the
crystal. The interface surfaces between neighboring proteins identify the pair-wise interactions of residues involved in crystal
contacts [65].
variants (PDB codes: 1BQ8, 1BQ9) [36] were crystal-
lized under identical experimental conditions and show
identical crystal forms, because the mutated region is not
involved in any crystal contact.
This analysis of crystal contacts is not necessarily ex-
haustive if we assume that non-specific interactions can
stem from hundreds of thousands of protein-protein ori-
entations [68]. Yet these interactions have to be suf-
ficiently strong compared to kBT in order to actually
drive protein assembly. This threshold dramatically re-
duces the number of potential crystal contacts, and thus
relevant patches. To assess the randomness of crystal
contacts, we determine the PMF for three alternate pro-
tein orientations that one may assume to be amongst the
most attractive. The first is a hybrid of interface 1a and
2a, which determines whether a given patch only inter-
acts with its partner patch. Figure 5 shows that the first
interaction is mostly repulsive and weakly attractive at
short range, in support of our patch-specific assumption.
The second and third are the top two scored configura-
tion found by RosettaDock [69, 70]. The highest scored
interaction is as attractive as actual crystal contacts, but
would result in a crystal of dimers because the surface re-
gions of the two interacting chains involved in the contact
are the same. MD simulations show that the solid angle
spanned by this interaction is very narrow (cos δ = 0.99),
which suggests that this contact is much more orien-
tationally specific than typical crystal contacts (patch
widths in Table III). In addition, the PDB shows no
record of a rubredoxin dimer, which suggests that the re-
maining open surface of the dimer presents no patch suf-
ficiently strong to further drive crystal assembly. Finally,
the second strongest interaction predicted by Rosetta is
both non-dimeric and non-attractive (not shown), and
7we expect other contacts to result in even weaker inter-
actions. This finding supports the notion that crystal
contacts, although biologically non-functional, are defi-
nitely not in all ways similar to random protein-protein
interfaces. They are undeniably characterized by some
level of chemical complementarity and specificity.
FIG. 5. PMF of two alternate protein-protein interfaces. Ran-
dom interface 1 is built using one chain oriented as in interface
1a and one chain oriented as in interface 2a (solid line). Ran-
dom interface 2 is the most favorable configuration found by
RosettaDock (dashed line).
B. Crystal contacts of mut-RbPa.
Mut-RbPa has crystal contacts that are all substan-
tially different from those of the previous two proteins.
Although each chain has six nearest neighbors, only four
of them (forming two interfaces) are sufficiently close to
contribute to the pair attraction (Fig. 4C). Interface 2c is
mostly hydrophobic, but the hydrophobic component on
interface 1c is relatively small. The attraction is instead
dominated by a salt-bridge between Arg50 and Asp35,
which is stable between 1.9 and 2.1 nm, while at larger
distances water fills the gap between the two proteins.
The PMF therefore first plateaus, then rapidly increases
(Fig. 4C). The resulting distance at crystal contact for
interface 1c and 2c are congruent with the PMF mini-
mum.
Assuming that the strongest pair interaction deter-
mines the nucleation process, one may wonder why in-
terface 1c in mut-RbPa is absent from the crystal con-
tacts of wt-RbPf. We note that interface 1c misses the
C-terminus and Lys50 is mutated to arginine. Delet-
ing the C-terminus allows the two chains to fit closely
together and the arginine residue to form a salt bridge
with Asp35 (Fig. 6A). To test whether the creation of
this new interface can be attributed to the shorter tail of
mut-RbPa, we delete the C-terminus of wt-RbPf and fit
the two chains to the structure of interface 1c (Fig. 6B).
The PMF indicates that the interaction between the two
chains remains non-attractive (Fig. 6C), i.e. lysine and
arginine are not here interchangeable. Closer examina-
tion reveals that both Arg50 nitrogen groups interact
with the other chain through a salt bridge and a hydrogen
bond. Conversely, lysine offers a single nitrogen group to
compete with solvation. In agreement with lysine’s sol-
FIG. 6. A: Detail of the interaction between Arg50 and the
neighboring chain in interface 1 in mut-RbPa. The solid line
identifies the salt-bridge with Asp35 and the dashed line the
hydrogen bond with the carbonyl group of Asn21. B: Inter-
action of Lys50 with the neighboring chain after deleting the
last residue of wt-RbPf and fitting the structure in order to
overlap the crystal contact of mut-RbPa. The lysine residue
can either form the hydrogen bond or the salt-bridge, but not
both. Bond lengths (in A˚) are reported above the bond lines.
C: The PMF for the interface represented in panel B indicates
a neutral interaction between the two chains.
vation free energy being nearly twice more negative than
that of arginine [71], we find that lysine solvates immedi-
ately and does not interact with the other protein chain.
This finding suggests that the lysine at position 50 in
RbPf prevents the formation of a crystal contact analo-
gous to interface 1c in mut-RbPa. Replacing this lysine
with an arginine should thus favor a 1c-like interface in
RbPf and allow wt-RbPf and mut-RbPf to crystallize iso-
morphously to mut-RbPa.
C. Patchy particle models and phase diagrams.
Figure 7 illustrates the phase diagram for patchy par-
ticle models parameterized with the above MD results
for each protein. The fluid-solid line (F/S) marks the
coexistence conditions between solvated and crystallized
proteins, while the gas-liquid coexistence line (G/L) iden-
tifies the conditions under which high and low concen-
tration solutions of proteins can coexist. As expected
from the relatively short radial range of the attraction
(∼ 5 − 15%σ), in all cases the G/L line is metastable
with respect to the solubility line. The observed relative
variations of the attraction width (between 1 and 5%)
and range (between 5 and 10%σ) only change the melt-
8FIG. 7. Phase diagram for wt-RbPf, mut-RbPf and mut-
RbPa at 3 M of NaCl and wt-RbPf at 45 mM of NaCl. The
fluid-solid lines (F/S) for the four systems are represented re-
spectively by left-pointing triangles, circles, squares and right-
pointed triangles. The gas-liquid (G/L) are indicated by the
corresponding empty symbols (thicker edge symbol indicates
the critical point). The dashed lines correspond to the tem-
peratures at which the crystallization experiments were con-
ducted. The dotted line indicates the maximum reachable
density for the experimental protein solution of wt-RbPf.
ing temperature by up to 3% and the critical tempera-
ture by up to 8%, which supports the robustness of the
schematic models in the crystallization zone. The phase
diagrams allow us to predict the conditions under which
crystallization can be successful, i.e., between the solubil-
ity line and the critical point, the conditions under which
the protein will be undersaturated, i.e., above the F/S
line, and the conditions under which over-nucleation and
amorphous aggregation occurs, i.e., below the G/L line.
These predictions can be straightforwardly validated by
comparing these phase diagrams with the experimental
crystallization conditions. Remarkably, for all three pro-
teins the experimental temperature falls within 10% of
the crystallization gap, which is comparable with the es-
timated uncertainty of the coexistence lines due to the
error in the MD simulations.
In the case of wt-RbPf, it is not unreasonable that an
unusual high density has to be reached to cross the sol-
ubility line. Given the initial experimental protein and
salt concentrations in the sample and in the buffer, the
protein concentration can reach up to ρ = NV ≈ 0.55[72].
This observation in conjunction with the higher error of
the MD results for interface 2a rationalizes the more lim-
ited agreement between model and experiment in this
case.
For the phase diagram of mut-RbPa, we find the tem-
perature at which the protein was experimentally crystal-
lized (293 K) to be very near the model’s critical tempera-
ture, close to the amorphous regime. Interestingly, in the
same crystallography study, the wild type of RbPa was
crystallized at a poorer resolution and in a different unit
cell by adding dioxane to the sample [38]. By comparing
FIG. 8. PMF as a function of COM-COM distance for the two
interfaces involving Arg5 (explicitly shown in the left panel)
in wt-RbPa. The simulations, run at 3 M of NaCl and with-
out dioxane, show much weaker attraction than the crystal
contacts of mut-RbPa.
the crystal forms of the two proteins, we identify one mu-
tation (Arg5) that is involved in two crystal contacts of
the wild-type, but not of the mutant, which can in princi-
ple trigger the formation of a different crystal form. Sim-
ulations show, however, that the contacts involving the
mutation are much less attractive than the mut-RbPa
crystal contacts in the absence of dioxane (Fig. 8). This
result suggests that the wild-type should crystallize iso-
morphously to the mutant under the mutant’s crystal-
lization condition, i.e. without dioxane. Because similar
crystal contacts should correspond to similar phase dia-
grams, we expect these solution conditions to be near the
G/L line for the wild-type, as they were to the mutant’s.
It is therefore not surprising that the study reports exces-
sive nucleation of the wild-type when crystallization was
attempted without dioxane. Small perturbation of the
wild type interactions due to the mutations or to vari-
ations in the experimental solution concentrations may
have sufficed to tilt the system below the G/L line. Two
experimental approaches can then overcome the problem:
weakening the protein interactions by changing the solu-
tion conditions, or increasing the solution temperature.
The authors of the study, as many before them, opted
for the first approach and added dioxane to the solution.
This additive enhances electrostatic interactions and re-
sults in an effective repulsion between proteins, which
(naturally) carry the same net charge. Increasing the
temperature might, however, have been a better strat-
egy than adding a cosolute, in order to reproducibly ob-
tain high-resolution crystals. Such strategy has already
proven useful in obtaining better quality crystals in other
proteins, but it is “often neglected despite its proven im-
pact” [73, 74], possibly because of the poor microscopic
understanding of the approach until now.
It is important to note that the assumption of simi-
lar phase diagrams only holds if the residues that differ
between the two proteins do not strongly affect protein-
protein interactions, which is not always the case. Com-
paring wt-RbPf and mut-RbPa shows that a single mu-
tation (lysine to arginine) there dramatically affects the
crystal organization (Sec. III B).
9D. Effect of low salt concentration on wt-RbPf.
All crystallized rubredoxins have been precipitated out
of relatively high salt concentration (∼3 M) solutions. In
order to get a clearer understanding of this feature and to
validate the robustness of our method, we also calculate
the PMF of wt-RbPf at low salt concentration (45 mM).
This approach enables us to identify the differences that
make this solution condition unsuitable to crystallizing
rubredoxin.
FIG. 9. PMF as a function of COM-COM distance for wt-
RbPf in a 45 mM solution of NaCl.
Salt only weakly perturbs the PMF of interfaces dom-
inated by hydrophobic attraction (within the simulation
error, Fig. 9), in agreement with NaCl being a weak
salting-out agent [75]. Interface 1a, however, becomes
significantly less attractive at 45 mM NaCl (Fig. 10).
The microscopic origin of this effect is detected by exam-
ining the behavior of ions around the interface at high
and intermediate salt concentration (3 M and 0.5 M of
NaCl).
FIG. 10. PMF of interface 1 for wt-RbPf at different salt
concentrations and for the E49A mutant at 45 mM of NaCl
(SER).
Interface 1a contains six negatively (two on one chain
and four on the other) and three positively (all on a sin-
FIG. 11. Number density of counter ions as a function of
distance from the charge of three different residues: Glu49 on
chain A (solid), Lys6 on chain A (dashed) and the oxygen of
Gly22 on chain B (point-dashed). Black lines refer to the 3 M
NaCl simulations, grey lines to the 0.5 M NaCl simulations.
The inset shows the location of the residues at crystal contact.
At low salt concentration Glu49 interacts with Lys6 on the
same chain (arrow a), while at higher salt concentration Glu49
is screened and Lys6 interacts with the carboxyl group of
Gly22 on the other chain (arrow b).
gle chain) charged residues. It should thus be highly hy-
drated, as it is found in both the PDB structure (1BRF)
and the simulations. The overall electrostatic repul-
sion between the two proteins at this interface is thus
weakly screened at low salt concentration, but the situa-
tion is different at high salt concentration. The positively
charged residues at the edge of the interface are then ac-
cessible to ions and therefore screened, while the nega-
tively charged residues buried in the core of the interface
are much less screened. As a result, like charge repul-
sions between residues on different proteins and opposite-
charge attractions between residues on the same protein
are weakened, while unlike charges on different proteins
at the core of the interface remain essentially unscreened.
A net effective attraction between the two chains is thus
observed (Fig. 11). In other words, when no ions are
present, the positively charged Lys6 interacts with Glu49
on the same chain and not with the polar carboxyl of
Gly22 on the other chain. If the salt concentration in-
creases, Glu49 is entirely screened by counter ions be-
yond 2 A˚ (black solid line), but both Lys6 and Gly22
still interact with each other. To further support this in-
terpretation, we observe that by replacing Glu49 with a
neutral alanine the resulting PMF is attractive even at
low salt concentration (SER profile in Fig. 10).
The phase diagram obtained by parameterizing the
model’s interface 1a at low salt concentration pushes the
solubility line to lower temperature and moves the crys-
tallization gap further away from the experimentally ac-
10
cessible temperature range. The model, therefore, sug-
gests a nearly-quantitative explanation for choosing high
salt crystallization conditions for this family of proteins.
IV. DISCUSSION
From this proof-of-concept study, we can draw micro-
scopic insights about the underlying structural biology
and soft matter motivations for its inception.
A. Surface Entropy Reduction.
The surface entropy reduction mutagenesis approach,
rooted in extended crystallographic expertise [18], has
been statistically justified by mining the PDB [16]. Al-
though its microscopic basis lies on reducing the entropic
cost of crystallization, it also implicitly accounts for other
effects by targeting specific residue types (lysines and glu-
tamic acids) and not other equivalently highly entropic
side chains (arginines and aspartic acids) [76].
The analysis of crystal contacts presented here allows
us to go beyond the statistical justifications and offers a
physical rationale for the observed difference in behav-
ior between residues with a similar entropy. In interface
1c of mut-RbPa, for instance, we verify that replacing
Arg50 with a lysine significantly weakens the energetic
interaction, in spite of the two residues having a similar
entropy [16]. In this specific case, the different propen-
sity of forming multiple intermolecular interactions and
the solvation free energy play key roles in distinguish-
ing the contribution of the two side chains. This effect
thus offers an explanation as to why lysine is a good SER
target, while arginine is not.
We also obtain an example where a targeted mutation
is advantageous from both a SER and an energetic point
of view. We show that at low salt concentration wt-RbPf
would not crystallize, or at least not in the same form.
As observed in the analysis of interface 1a, the electro-
static interaction of Glu49 with Lys6 at low salt con-
centration prevents the inter-chain interaction between
Lys6 and Gly22 and therefore also the protein’s crys-
tallization. For wt-RbPf, the SER approach specifically
recommends replacing Glu49 with alanine [76]. Mutat-
ing Glu49 deletes the responsible charge and strengthens
the pair interaction by an alternate route to increasing
the salt concentration. In this situation, the suggested
mutation would likely help crystal formation in part be-
cause it reduces the surface entropy, but mainly because
it changes the interface electrostatic potential (Fig. 10).
The microscopic analysis of the crystal contacts in this
work provides physical evidence that both support and
modulate the statistical findings about them [16]. For
one thing, compression of the lattice unit cells and read-
justments of polar residues are common effects of crys-
tal freezing [77], which can bias analyses based on PDB
structures alone. Our solvated approach overrides some
of these biases by simulating experimental crystalliza-
tion temperatures, where the protein properties are av-
eraged over a thermal ensemble of configurations. This
clarified picture also suggests ways to improve the suc-
cess of SER-like methods. Analyzing the nature of the
surrounding amino acids along the chain, for instance,
should help identify residues that weaken interactions by
disrupting hydrophobic patches or by competing with fa-
vorable inter-chain interactions.
The general strategy of strengthening protein interac-
tions does not, however, always results in better crystals.
The connection we establish between protein-protein in-
teractions and the overall protein-solution phase diagram
clarifies this key point. If a protein gels or over nucleates,
the crystallization conditions should instead be chosen
to weaken these interactions, which can be achieved, for
some maybe counterintuitively, by increasing tempera-
ture and thus entropy’s contribution to protein-protein
interactions.
B. Patchy models.
The central premise that the phase behavior of crystal-
lizing proteins could be understood from that of particles
with short-range anisotropic interactions is here verified,
at least for a set of small and compact globular proteins.
The typical regime for successful experimental crystal-
lization is intermediate between the metastable critical
point and the solubility line at low to intermediate pro-
tein concentrations, which results in open crystal struc-
tures dominated by directional interactions [60].
It is by now well understood that reducing the range
and surface coverage of attraction lowers the critical
temperature and broadens the crystallization regime
[31, 32, 78]. The critical point may or may not assist nu-
cleation [79, 80], but the question is of little relevance if
the protein is in any case highly soluble. Our study shows
that in a low-salt aqueous environment RbPf and its mu-
tants, for instance, do not crystallize because their solu-
bility lines lie either at very low temperatures or at high
densities. The addition of salt to the solution strengthens
the pair interaction, but does not significantly affect its
range or width, except for incompletely screened electro-
static interactions. The pair interactions therefore nat-
urally results in an attraction range that lies between 1
and 3 A˚. The parameter that most affects solubility is
the interaction strength. The phase diagram in Fig. 7
shows that in order to achieve reasonable solubility at
room temperature, the average interaction strength per
patch should be of order 8 kJ/mol for a protein with six
crystal contacts and of 20 kJ/mol for a protein with four.
A larger protein would shrink the fraction of the protein
diameter σ over which the attraction is felt as well as its
angular span. Although tightening the fractional range
by an order of magnitude dramatically affects the criti-
cal point location, it only weakly perturbs the position
of the solubility line. If anything, crystallization may
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then become easier. The fact that it generally is not
highlights the incompleteness of this description, which
should then probably include a larger number of patches
for larger proteins. We get back to this question in the
conclusion.
A common assumption in patchy particle models is
that the patch-patch interactions responsible for crystal-
lization are essentially identical. Our simulations clearly
show that it is not the case in proteins. Comparing the
phase diagram of wt-RbPf and mut-RbPa indicates that
it may be more efficient to have many weaker patches
than few stronger patches, in order to decrease the sol-
ubility of a protein. If we rescale the temperature over
the average energy per particle in the crystal (∼8 kBT
for wt-RbPf and ∼16 kBT for mut-RbPa), the solubility
line of mut-RbPa drops below that of wt-RbPf, indicat-
ing that mut-RbPf is crystallized by making up for the
absence of an interface by having a drastically increased
attraction strength for the others. This observation mo-
tivates the study of how the distribution of energy across
patches affects the phase diagram [64].
Modifying the interaction strength is equivalent to
rescaling temperature. A patchy model with stronger in-
teractions maps to the same phase diagram with higher
temperatures. From a practical point of view, except
for small changes to solution temperatures, tuning the
strength of the interaction is, however, quite difficult to
achieve and typically requires a detailed microscopic un-
derstanding of the system. Our results show that even
small details, such as mutating a lysine to an arginine, or
the preferential screening observed at high salt concen-
tration, can significantly affect the interaction. Echoing
the SER discussion, we thus urge for more systematic
atomistic-level studies of this question.
V. CONCLUSION
In this paper, we have studied the interaction of three
closely related proteins of the rubredoxin family using
an approach that bridges the structural biology and soft
matter descriptions of protein crystallization. It allowed
us to characterize representative values of protein-protein
interactions and to obtain reasonable phase diagrams,
providing a microscopic explanation of why certain sim-
ple mutations can dramatically affect a protein’s crys-
tallization behavior. The correspondence between pro-
tein crystallization and patchy models phase diagrams
provides guidelines to avoid gelation and over-nucleation
and, more generally, draw stronger parallels between
schematic models for soft matter and protein assembly.
Because the goal of this study is to verify the corre-
spondence between patchy particle models and real pro-
teins, and to identify microscopic mechanisms that trig-
ger these interactions, we have here focused on a protein
for which structure and crystal contacts are known. In
this case the interacting patches are directly extracted
from the known protein crystal contacts. Although one
does not typically have access to such detailed informa-
tion when attempting to crystallize a protein de novo,
this approach can nonetheless be of merit even when
patch identification cannot be directly read off from a
PDB file. For instance, if a low-resolution crystal is avail-
able, a rough estimate of the protein structure can be fit
to the electron density map and the crystal contacts so
analyzed. MD simulations would then allow to relax and
correct a defective initial structure and give reasonable
results for the crystal contact interactions. The phase
diagram of the resulting model can be used to guide
subsequent attempts at improving the crystal resolution.
Similarly, if the structure of a homologue or a mutant is
known, MD simulations of its crystal contacts in which
the differences between the target protein and the one
available are replaced in vitro can be used to obtain an
initial phase diagram and tune the conditions to obtain
an isomorphous crystal for the target protein.
In the worst case scenario, the case in which nothing
is known beyond a protein’s primary sequence, our ap-
proach has to be preceded by some analysis of the protein
surface. Multiple iterations between simulations and ex-
periments would then likely be necessary. Protein folding
algorithms, although far from reliably and systematically
predicting the full three-dimensional structure of a pro-
tein, may help guess which residues are likely to be on
the surface and closed to which others [81]. This rough
surface map could then be used to identify problematic
regions that hinder protein-protein interactions and thus
determine good targets for mutations, as suggested in
Section IV A. Our microscopic analysis further suggests
that crystal contacts are mostly characterized by specific
patterns of hydrophobic, charged and polar residues and
by the presence of few residues, i.e. arginine, that have
peculiar chemistry. This observation justifies and encour-
ages extensive simulations to characterize the interaction
between patterns of these residues in different solution
conditions. This information could be collected in a dic-
tionary that is searched to find potential crystal contacts
on a protein given a coarse map of its surface. The set
of potential crystal contacts could then be used as set
of patches in the model to obtain a first guess of phase
diagram to tune crystallization conditions. The location
of the patches, although important in the actual protein
and in the formation of a crystal versus another, only
weakly affects crystallization in patchy models [64] and
can, therefore, be adjusted in a second step. We antici-
pate that future studies will clarify the usefulness of such
a scheme.
Considering more complex proteins would also require
introducing additional features to the schematic mod-
els. For example, some proteins assemble in more than
one crystal form, each involving a distinct set of crys-
tal contacts. Consequently, they should be character-
ized by a larger set of patches. Although different crys-
tal forms might result in very similar protein structures,
they are nevertheless interesting because they can pro-
duce higher resolution crystals or highlight dynamical
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features that would otherwise be unnoticed in the static
crystallographic view, such as the hinge-bending angle in
lysozyme [82]. The position and the parameterization of
the patches may also not be kept fixed if conformational
changes occur on a timescale similar to crystallization,
such as in intrinsically disordered proteins. Work in this
direction should help clarify both the soft matter and
structural biology viewpoints.
ACKNOWLEDGMENTS
We thank Daan Frenkel, Dewey McCafferty, Terrence
Oas, David and Jane Richardson, Weitao Yang and Wei
Yang for various conversations. We acknowledge support
from National Science Foundation Grant No. NSF DMR-
1055586 and National Institute of Health Grant No. NIH
GM-061870.
[1] S. Grzesiek and H.-J. Sass, Curr. Opin. Struct. Biol. 19,
585 (2009).
[2] A. McPherson, Crystallization of Biological Macro-
molecules (CSHL Press, Cold Spring Harbor, 1999).
[3] N. E. Chayen and E. Saridakis, Nature Methods 5, 147
(2008).
[4] N. E. Chayen, in Advances in Protein Chemistry and
Structural Biology, edited by J. Andrzej (Academic Press,
London, 2009), Vol. 77, pp. 1–22.
[5] T. L. Blundell, H. Jhoti, and C. Abell, Nat. Rev. Drug.
Discov. 1, 45 (2002).
[6] P. Kuhn, K. Wilson, M. G. Patch, and R. C. Stevens,
Curr. Opin. Chem. Biol. 6, 704 (2002).
[7] T. L. Blundell and S. Patel, Curr. Opin. Pharmacol. 4,
490 (2004).
[8] I. Tickle, A. Sharff, M. Vinkovic, J. Yon, and H. Jhoti,
Chem. Soc. Rev. 33, 558 (2004).
[9] D. B. Kitchen, H. Decornez, J. R. Furr, and J. Bajorath,
Nat. Rev. Drug. Discov. 3, 935 (2004).
[10] M. Congreve, C. W. Murray, and T. L. Blundell, Drug.
Discov. Today 10, 895 (2005).
[11] N. Huebsch and D. J. Mooney, Nature 462, 426 (2009).
[12] Z. Derewenda, Acta Crystallogr D Biol. Crystallogr. 66,
604 (2010).
[13] M. J. Anderson, C. L. Hansen, and S. R. Quake, Proc.
Natl. Acad. Sci. USA 103, 16746 (2006).
[14] E. Saridakis and N. E. Chayen, Trends Biotechnol. 27,
99 (2009).
[15] The meaning of non-specific protein-protein interactions
depends on the disciplinary context. In chemistry, it dis-
tinguishes certain attraction forces from others, although
the classification of the various physical mechanisms in
not unambiguous [83, (§ 18.8)]. In biophysics, the dis-
tinction between specific and non-specific interactions
typically relies on the existence of an energy gap that
clearly divides a single, strong (specific) interaction from
the other (non-specific) ones [84, 85]. In molecular bi-
ology, specific interactions are deemed responsible for
the stoichiometric recognition of a given target, while
non-specific interactions arise from the promiscuous yet
non-biologically relevant association of molecules [86–
89]. Specific interactions have thus been evolutionarily
tuned to be free-energetically strong and geometrically
oriented, while non-specific attractions have not. This
general weakness, however, may itself have evolved so as
to prevent pathological aggregation [84, 90]. Note that
although these three definitions are not necessarily or-
thogonal to one another, we here specifically aim to clar-
ify the last one. When applied to crystal contacts it has
indeed been used to suggest that these biologically non-
functional interactions are in many ways indistinguish-
able from interfaces obtained by randomly bringing two
proteins together [84].
[16] M. Cieslik and Z. S. Derewenda, Acta Crystallogr D Biol.
Crystallogr. 65, 500 (2009).
[17] W. N. Price et al., Nat. Biotechnol. 27, 51 (2009).
[18] Z. S. Derewenda, Structure 12, 529 (2004).
[19] C. J. Lanci, C. M. MacDermaid, S.-g. Kang, R. Acharya,
B. North, X. Yang, X. J. Qiu, W. F. DeGrado, and J. G.
Saven, Proc. Natl. Acad. Sci. USA 109, 7304 (2012).
[20] A. P. Gast, C. K. Hall, and W. B. Russel, J. Colloid
Interface Sci. 96, 251 (1983).
[21] M. H. J. Hagen and D. Frenkel, J. Chem. Phys. 101,
4093 (1994).
[22] A. Lomakin, N. Asherie, and G. B. Benedek, J. Chem.
Phys. 104, 1646 (1996).
[23] D. Rosenbaum, P. C. Zamora, and C. F. Zukoski, Phys.
Rev. Lett. 76, 150 (1996).
[24] N. E. Chayen, Progr. Biophys. Mol. Biol. 88, 329 (2005).
[25] P. J. Lu, E. Zaccarelli, F. Ciulla, A. B. Schofield, F.
Sciortino, and D. A. Weitz, Nature 453, 499 (2008).
[26] C. Haas, J. Drenth, and W. W. Wilson, J. Phys. Chem.
B 103, 2808 (1999).
[27] R. A. Curtis, H. W. Blanch, and J. M. Prausnitz, J. Phys.
Chem. B 105, 2445 (2001).
[28] A. Lomakin, N. Asherie, and G. B. Benedek, Proc. Natl.
Acad. Sci. USA 96, 9465 (1999).
[29] J. J. McManus, A. Lomakin, O. Ogun, A. Pande, M.
Basan, J. Pande, and G. B. Benedek, Proc. Natl. Acad.
Sci. USA 104, 16856 (2007).
[30] C. Go¨gelein, G. Na¨gele, R. Tuinier, T. Gibaud, A. Strad-
ner, and P. Schurtenberger, J. Chem. Phys. 129, 085102
(2008).
[31] E. Bianchi, R. Blaak, and C. N. Likos, Phys. Chem.
Chem. Phys. 13, 6397 (2011).
[32] N. Kern and D. Frenkel, J. Chem. Phys. 118, 9882
(2003).
13
[33] P. Charbonneau and D. Frenkel, J. Chem. Phys. 126,
196101 (2007).
[34] G. Foffi and F. Sciortino, J. Phys. Chem. B 111, 9702
(2007).
[35] G. Pellicane, G. Smith, and L. Sarkisov, Phys. Rev. Lett.
101, 248102 (2008).
[36] R. Bau, D. C. Rees, D. M. Kurtz, R. A. Scott, H. S.
Huang, M. W. W. Adams, and M. K. Eidsness, J. Biol.
Inorg. Chem. 3, 484 (1998).
[37] T. Chatake, K. Kurihara, I. Tanaka, I. Tsyba, R. Bau,
F. E. Jenney, M. W. W. Adams, and N. Niimura, Acta
Crystallogr D Biol. Crystallogr. 60, 1364 (2004).
[38] H. Bonisch, C. L. Schmidt, P. Bianco, and R. Ladenstein,
Acta Crystallogr D Biol. Crystallogr. 61, 990 (2005).
[39] A. De Simone, C. Kitchen, A. H. Kwan, M. Sunde, C. M.
Dobson, and D. Frenkel, Proc. Natl. Acad. Sci. USA
(2012).
[40] B. Dalhus et al., J. Mol. Biol. 318, 707 (2002).
[41] B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl,
J. Chem. Theory Comput. 4, 435 (2008).
[42] V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg,
and C. Simmerling, Proteins 65, 712 (2006).
[43] W. L. Jorgensen, J. Chandrasekhar, J. D. Madura, R. W.
Impey, and M. L. Klein, J. Chem. Phys. 79, 926 (1983).
[44] J. Aaqvist, J. Phys. Chem. 94, 8021 (1990).
[45] S. Nos, Mol. Phys. 52, 255 (1984).
[46] W. G. Hoover, Phys. Rev. A 31, 1695 (1985).
[47] M. Parrinello and A. Rahman, J. Appl. Phys. 52, 7182
(1981).
[48] U. Essmann, L. Perera, M. L. Berkowitz, T. Darden,
H. Lee, and L. G. Pedersen, J. Chem. Phys. 103, 8577
(1995).
[49] B. Hess, H. Bekker, H. J. C. Berendsen, and J. G. E. M.
Fraaije, J. Comput. Chem. 18, 1463 (1997).
[50] M. J. Frisch et al., Gaussian 03, Revision C.02.
[51] A. D. Becke, J. Chem. Phys. 98, 5648 (1993).
[52] C. Lee, W. Yang, and R. G. Parr, Phys. Rev. B 37, 785
(1988).
[53] J. M. Seminario, International Journal of Quantum
Chemistry 60, 1271 (1996).
[54] V. B. Chen, W. B. Arendall, III, J. J. Headd, D. A.
Keedy, R. M. Immormino, G. J. Kapral, L. W. Murray,
J. S. Richardson, and D. C. Richardson, Acta Crystallo-
graphica Section D 66, 12 (2010).
[55] J. S. Hub, B. L. de Groot, and D. van der Spoel, J. Chem.
Theory Comput. 6, 3713 (2010).
[56] K. Lindorff-Larsen, R. B. Best, M. A. DePristo, C. M.
Dobson, and M. Vendruscolo, Nature 433, 128 (2005).
[57] P. R. Blake, J. B. Park, Z. H. Zhou, D. R. Hare, M. W.
Adams, and M. F. Summers, Protein Sci 1, 1508 (1992).
[58] K. Lindorff-Larsen, P. Maragakis, S. Piana, M. P. East-
wood, R. O. Dror, and D. E. Shaw, PLoS ONE 7, e32131
(2012).
[59] R. P. Sear, J. Chem. Phys. 111, 4800 (1999).
[60] N. Dorsaz, L. Filion, F. Smallenburg, and D. Frenkel,
Faraday Discuss. 159, 9 (2012).
[61] D. Frenkel and B. Smit, Understanding Molecular Simu-
lation (Academic Press, London, 2001).
[62] A. Z. Panagiotopoulos, Mol. Phys. 61, 813 (1987).
[63] C. Vega, E. Sanz, J. L. F. Abascal, and E. G. Noya, J.
Phys.-Condens. Mat. 20, 153101 (2008).
[64] D. Fusco and P. Charbonneau, Phys. Rev. E 88, 012721
(2013).
[65] Y.-E. A. Ban, H. Edelsbrunner, and J. Rudolph, J ACM
53, 361 (2006).
[66] S. D. Black and D. R. Mould, Anal. Biochem. 193, 72
(1991).
[67] J. J. Headd, Y. E. Ban, P. Brown, H. Edelsbrunner, M.
Vaidya, and J. Rudolph, J. Proteome Res. 6, 2576 (2007).
[68] J. D. Schmit and K. Dill, J. Am. Chem. Soc. 134, 3934
(2012).
[69] J. J. Gray, S. Moughon, C. Wang, O. Schueler-Furman,
B. Kuhlman, C. A. Rohl, and D. Baker, J. Mol. Biol.
331, 281 (2003).
[70] S. Chaudhury, A. Sircar, A. Sivasubramanian, M.
Berrondo, and J. J. Gray, Proteins 69, 793 (2007).
[71] P. Bash, U. Singh, R. Langridge, and P. Kollman, Science
236, 564 (1987).
[72] We define ρip =
Np
V i
as the initial protein density, ρisalt =
Nsalt
V i
as the initial salt density and ρfsalt =
Nsalt
V f
as the
final salt density assumed to be equal to the salt density
in the buffer, then the final protein density is
ρfp =
Np
V f
=
Np
Nsalt
ρfsalt =
Np
Nsalt
ρfsalt
V i
V i
=
ρip
ρisalt
ρfsalt. (7)
.
[73] M. J. Landsberg, J. Bond, C. L. Gee, J. L. Martin, and
B. Hankamer, Acta Crystallogr D Biol. Crystallogr. 62,
559 (2006).
[74] M. Benvenuti and S. Mangani, Nat. Protocols 2, 1633
(2007).
[75] R. Zangi, M. Hagen, and B. J. Berne, J. Am. Chem. Soc.
129, 4678 (2007).
[76] L. Goldschmidt, D. R. Cooper, Z. S. Derewenda, and D.
Eisenberg, Protein Sci. 16, 1569 (2007).
[77] D. H. Juers and B. W. Matthews, J. Mol. Biol. 311, 851
(2001).
[78] L. Vega, E. d. Miguel, L. F. Rull, G. Jackson, and I. A.
McLure, J. Chem. Phys. 96, 2296 (1992).
[79] P. R. ten Wolde and D. Frenkel, Science 277, 1975
(1997).
[80] T. K. Haxton and S. Whitelam, Soft Matter 8, 3558
(2012).
[81] K. A. Dill and J. L. MacCallum, Science 338, 1042
(2012).
[82] X. jun Zhang, J. A. Wozniak, and B. W. Matthews, J.
Mol. Biol. 250, 527 (1995).
[83] J. N. Israelachvili, Intermolecular and surface forces
(Academic Press, San Diego, 1991).
[84] J. Janin, Progr. Biophys. Mol. Biol. 64, 145 (1995).
[85] M. E. Johnson and G. Hummer, Proc. Natl. Acad. Sci.
USA 108, 603 (2011).
[86] J. Janin and F. Rodier, Proteins 23, 580 (1995).
[87] O. Carugo and P. Argos, Protein Sci. 6, 2261 (1997).
[88] K. D. Wilkinson, Quantitative Analysis of Protein-
Protein Interactions (Humana Press, ADDRESS, 2004),
Vol. 261, pp. 15–31.
[89] T. Zhuang, B. K. Jap, and C. R. Sanders, J. Am.
Chem. Soc. 133, 20571 (2011), see also Cable J., Na-
ture Structural Biology technical highlights, 2002. SBKB
[doi:10.1038/sbkb.2012.108].
[90] J. P. K. Doye, A. A. Louis, and M. Vendruscolo, Physical
Biology 1, P9 (2004).
